Further, HCC cells treated with fragment 1 exhibited reduced expression of P62, LC3B-II, PINK1, and Parkin (Figure 10D), while these effects were not observed in HCC cells treated with fragment 2 (Figure 10A-C and Figure S7). This evidence concerns the gene PRKN and hepatocellular carcinoma.